Editorial
Optimizing the management of hepatobiliary neoplasms: a multidisciplinary and molecular challenge
Journal of Gastrointestinal Oncology
2017;
8
(2)
:213-214
.
(18 April 2017)
Review Article
Locoregional and systemic therapy for hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2017;
8
(2)
:215-228
.
(18 April 2017)
Viral hepatitis and hepatocellular carcinoma: etiology and management
Journal of Gastrointestinal Oncology
2017;
8
(2)
:229-242
.
(18 April 2017)
Systemic therapy for advanced hepatocellular carcinoma: an update
Journal of Gastrointestinal Oncology
2017;
8
(2)
:243-255
.
(18 April 2017)
Hepatocellular carcinoma (HCC): beyond sorafenib—chemotherapy
Journal of Gastrointestinal Oncology
2017;
8
(2)
:256-265
.
(18 April 2017)
Selective internal radiation therapy with SIR-Spheres in hepatocellular carcinoma and cholangiocarcinoma
Journal of Gastrointestinal Oncology
2017;
8
(2)
:266-278
.
(18 April 2017)
Radiation therapy for hepatobiliary malignancies
Journal of Gastrointestinal Oncology
2017;
8
(2)
:279-292
.
(18 April 2017)
Biliary cancer: intrahepatic cholangiocarcinoma vs. extrahepatic cholangiocarcinoma vs. gallbladder cancers: classification and therapeutic implications
Journal of Gastrointestinal Oncology
2017;
8
(2)
:293-301
.
(18 April 2017)
Adjuvant therapy in biliary tract and gall bladder carcinomas: a review
Journal of Gastrointestinal Oncology
2017;
8
(2)
:302-313
.
(18 April 2017)
Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function
Journal of Gastrointestinal Oncology
2017;
8
(2)
:314-323
.
(18 April 2017)
Targeted therapy in biliary tract cancers—current limitations and potentials in the future
Journal of Gastrointestinal Oncology
2017;
8
(2)
:324-336
.
(18 April 2017)
Original Article
Operative microwave ablation for hepatocellular carcinoma: a single center retrospective review of 219 patients
Journal of Gastrointestinal Oncology
2017;
8
(2)
:337-346
.
(18 April 2017)
Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy
Journal of Gastrointestinal Oncology
2017;
8
(2)
:347-351
.
(18 April 2017)
Long term responders to palliative chemotherapy for advanced biliary tract cancer
Journal of Gastrointestinal Oncology
2017;
8
(2)
:352-360
.
(18 April 2017)
Concurrent chemoradiation with volumetric modulated Arc therapy of patients treated for anal cancer—acute toxicity and treatment outcome
Journal of Gastrointestinal Oncology
2017;
8
(2)
:361-367
.
(18 April 2017)
Treatment of advanced Gall bladder cancer in the real world—can continuation chemotherapy improve outcomes?
Journal of Gastrointestinal Oncology
2017;
8
(2)
:368-376
.
(18 April 2017)
Case Report
Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion
Journal of Gastrointestinal Oncology
2017;
8
(2)
:E32-E38
.
(18 April 2017)
Disclosure:
The focused issue “Optimizing the management of hepatobiliary neoplasms: a multidisciplinary and molecular challenge” was commissioned by the Editorial office, Journal of Gastrointestinal Oncology without any sponsorship or funding. Jimmy J. Hwang served as the unpaid Guest Editor for the focused issue.
